Targeted therapy comes in several different types. Monoclonal antibodies and small-molecule drugs are the most common forms.
Monoclonal antibodies are drugs that block a specific target on the exterior of cancer cells. The target could potentially be in the vicinity of cancer. Toxic substances can also be delivered directly to cancer cells via monoclonal antibodies. They can, for example, aid chemotherapy and radiation therapy in reaching cancer cells more effectively. Immunotherapy can also include monoclonal antibodies.
Small-molecule drugs. Small-molecule drugs can stop cancer cells from multiplying and spreading by blocking the mechanism. This sort of targeted therapy includes angiogenesis inhibitors. The process of angiogenesis is the formation of new blood vessels. Blood arteries are required to transport nutrients to a tumor. It can develop and spread thanks to the nutrients. Angiogenesis inhibitors starve the tumor by preventing the formation of new blood vessels in the surrounding tissue.
Other immunotherapies, angiogenesis inhibitors, and apoptosis inducers are examples of targeted therapy (therapies that start cell death, or apoptosis).
Some targeted therapies are tailored to a particular cancer type. Other treatments are referred to as tumor-agnostic or site-agnostic. They treat cancers in any part of the body by concentrating on the precise genetic change rather than the cell type. Learn more about treatments that are tumor-agnostic.